HEALTHY BRAINS Act of 2026
- Sponsor
- Rep. Subramanyam, Suhas [D-VA-10]
- Committees
- Energy and Commerce Committee (primary)
- Last action
- Mar 3, 2026
Bottom line
The HEALTHY BRAINS Act aims to significantly expand federal research into the environmental causes of neurodegenerative diseases by establishing dedicated programs, collaborative centers, and substantial funding.
What it actually does
This bill mandates the Secretary of Health and Human Services to establish a comprehensive program for research, training, and health information dissemination concerning environmental risk factors of neurodegenerative diseases. It outlines specific research areas, requires inter-agency coordination and biennial reporting, and authorizes the creation of Collaborative Centers at research institutions, backed by $50 million in annual appropriations for five fiscal years.
Proponents argue
Supporters argue this bill addresses a critical gap in understanding neurodegenerative diseases by focusing on environmental factors, which are increasingly recognized as significant contributors to these complex conditions. They contend that a dedicated program will foster interdisciplinary research, lead to new prevention and treatment strategies, and ultimately reduce the burden of these devastating diseases on individuals and the healthcare system.
Opponents contend
No direct opposition is immediately apparent for a bill focused on expanding medical research into neurodegenerative diseases. Potential concerns, if any, might revolve around the overall level of federal spending, the allocation of research funds compared to other health priorities, or administrative complexities in establishing new centers and coordinating across existing agencies.
The bill is concise and clearly structured, allowing an informed reader to quickly grasp its provisions and implications.
Section 2, new Section 409K(a) of the Public Health Service Act
Establishment of Neurodegenerative Disease Environmental Research Program
This provision requires the Secretary of Health and Human Services to create a program dedicated to conducting and supporting research, training, and health information dissemination. The program's focus is specifically on environmental risk factors, including toxicant exposures, related to neurodegenerative diseases. This aims to centralize and enhance federal efforts in understanding these complex disease origins.
Supporters argue
Supporters argue this program is crucial for understanding the complex origins of neurodegenerative diseases, moving beyond purely genetic factors to include environmental triggers, which could unlock new avenues for prevention and therapy.
Critics contend
No specific opposition is typically raised against establishing research programs focused on public health issues, though general concerns about federal spending priorities might be voiced.
Tradeoffs
Balances the need for focused research on environmental factors with broader public health funding priorities and existing research efforts.
Section 2, new Section 409K(b) of the Public Health Service Act
Scope of Research and Focus Areas
This section specifies the types of research to be conducted or supported under the program. It mandates focus on potential environmental toxicants (e.g., volatile organic compounds, particulate matter, PFAS, heavy metals), their mechanistic interactions with disease, presymptomatic markers, and environmental health strategies. It also permits research into occupational and sociobehavioral factors, multifactorial causation, disease prevalence, gene-environment interplay, and physiological mechanisms driving neurodegeneration.
Section 2, new Section 409K(c) of the Public Health Service Act
HHS Coordination and Biennial Reporting
The Secretary of Health and Human Services is required to ensure coordination across all Department programs and activities to prevent duplication of efforts and expand funding for environmental health research. This includes leading a focused effort to fund new and existing centers. Additionally, the Secretary must submit a biennial report to specific Congressional committees detailing research findings, post these reports publicly on the HHS website, and include this information in an existing triennial report.
Section 2, new Section 409K(d) of the Public Health Service Act
Establishment of Collaborative Centers for Neurodegenerative Disease Environmental Research
This provision directs the Secretary to establish 'Collaborative Centers' at institutions of higher education, medical centers, or other appropriate entities. These centers are tasked with conducting basic, applied, and clinical research on environmental risk factors of neurodegenerative disease, including disease progression. They must be anchored in population-based environmental health research, conduct interdisciplinary and collaborative research, coordinate with existing HHS efforts, and collaborate with relevant partners and stakeholders.
Section 2, new Section 409K(d)(3) of the Public Health Service Act
Discretionary Activities of Collaborative Centers
Collaborative Centers, at their discretion, may provide career enhancement and training opportunities for scientists and health professionals (including stipends), conduct continuing education programs for health professionals, and disseminate research findings to the public. They may also establish a nationwide data system for neurodegenerative diseases, create an 'Environmental Contributions to Neurodegenerative Disease Information Clearinghouse,' and establish a national education program focused on environmental risk factors.
Section 2, new Section 409K(e) of the Public Health Service Act
Authorization of Appropriations for the Program
This provision authorizes the appropriation of $50,000,000 for each of fiscal years 2027 through 2031. This funding is intended to carry out all aspects of the new program established by this section, including research, training, health information dissemination, and the establishment and operation of the Collaborative Centers.
Specifies that the period of support for a Collaborative Center shall not exceed 5 years, but allows for extensions of one or more additional periods of not more than 5 years if the center's operations have been reviewed by an appropriate technical and scientific peer review group and recommended for extension.
Section 2, new Section 409K(d)(4) of the Public Health Service Act
Why it matters:This is standard legislative practice for federal grant and program durations, ensuring periodic review, accountability, and the ability to re-evaluate performance before committing to long-term funding.
Case for: Ensures that Collaborative Centers remain effective and accountable, allowing for the termination of underperforming centers and the renewal of successful ones based on merit and scientific progress. This promotes efficient use of federal funds.
Case against: Could create uncertainty for long-term research projects and institutional planning if extensions are not consistently granted, potentially hindering ambitious, multi-decade studies that require sustained funding and stability.
Estimated impact: Affects the long-term stability and planning of research institutions hosting these centers, influencing their ability to attract and retain top scientific talent for sustained research efforts.